 |
allogeneic ex vivo expanded unbilical cord blood cells |
|---|---|
| Trade Name | Stemex |
| Orphan Indication | Myelodysplastic syndromes |
| USA Market Approval | USA |
| USA Designation Date | 2010-02-01 00:00:00 |
| Sponsor | Gamida Cell - Teva Joint Venture;PO Box 34670; |
| |
allogeneic ex vivo expanded unbilical cord blood cells |
|---|---|
| Trade Name | Stemex |
| Orphan Indication | Myelodysplastic syndromes |
| USA Market Approval | USA |
| USA Designation Date | 2010-02-01 00:00:00 |
| Sponsor | Gamida Cell - Teva Joint Venture;PO Box 34670; |